# OnCo record nct00057811 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00057811/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00057811", "NCT00057811" ;
  schema:name "Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma"@en ;
  schema:description "A phase 2 trial of Doxorubicin, Cyclophosphamide, Methotrexate, Rasburicase, Leucovorin, Prednisone, Filgrastim, Rituximab, Cytarabine, Etoposide and Vincristine in Burkitt lymphoma and Acute lymphoblastic leukaemia, run by Children's Oncology Group, completed."@en ;
  schema:url <https://onco.cc/trials/nct00057811/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00057811> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/rasburicase/>, <https://onco.cc/drugs/leucovorin/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/filgrastim/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/vincristine/> .